Startup Atlas · Biotechnology
GlaxoSmithKline Pharmaceuticals Ltd Sector Top 20
UndisclosedTotal funding (tracked)
0Funding rounds
—Last round
GlaxoSmithKline Pharmaceuticals Ltd: Financial Breakdown
Figures below are FY2026, consolidated basis, compiled from filings and disclosures — every year cited to its source.
INR 382167 lakh revenue from operationsTotal revenue
INR 258164 lakh total expenses including finance and depreciationTotal expenses
INR 103598 lakh total group profit after taxNet profit
| Fiscal year | Revenue | Total expenses | EBITDA | Net profit / loss | Source |
|---|---|---|---|---|---|
| FY2026 | INR 382167 lakh revenue from operations | INR 258164 lakh total expenses including finance and depreciation | — | INR 103598 lakh total group profit after tax | source |
Nothing here is blurred or gated — every figure Atlas has is shown in full, free.
Sources & corrections.
Every fact on this page is compiled from cited public sources — follow the "source" links beside each entry. Profile sources: www.bseindia.com india-pharma.gsk.com india-pharma.gsk.com · Last verified 24 Oct 2026. · Report a correction